Cargando…

Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life‐threatening arrhythmia.

Detalles Bibliográficos
Autores principales:	Nordkin, Irina, Levinas, Tatyana, Rosenfeld, Inna, Halabi, Majdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813084/ https://www.ncbi.nlm.nih.gov/pubmed/33489188 http://dx.doi.org/10.1002/ccr3.3539

Ejemplares similares

Torsade de Pointes and Persistent QTc Prolongation after Intravenous Amiodarone
por: Kotsia, Anna P., et al.
Publicado: (2012)

Torsades de Pointes and Prolonged Self-Terminating Ventricular Fibrillation Induced by Amiodarone
por: Tziatzios, Georgios D, et al.
Publicado: (2020)

Incidence of drug-induced torsades de pointes with intravenous amiodarone
por: Shenthar, Jayaprakash, et al.
Publicado: (2017)

TORSADES DE POINTES IN ELDERLY PATIENT WITH PAROXYSMAL ATRIAL FIBRILLATION TREATED BY SHORT-TERM PARENTERAL AMIODARONE THERAPY
por: Lakušić, Nenad, et al.
Publicado: (2019)

Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
por: Takahashi, Koji, et al.
Publicado: (2021)

Amiodarone: Torsade de pointes: case report
Publicado: (2022)

Phenytoin in treatment of amiodarone-induced Torsades de pointes
por: Mukhopadhyay, Saibal, et al.
Publicado: (2012)

Torsades de Pointes associated with QT prolongation after catheter ablation of paroxysmal atrial fibrillation
por: Park, Yae Min, et al.
Publicado: (2017)

His Bundle Pacing in Amiodarone-Induced Complete Heart Block, QT Prolongation, and Torsade de Pointes
por: Tan, Vern Hsen, et al.
Publicado: (2020)

Torsade de Pointes Due to QT Prolongation after Pulmonary Vein Isolation for Persistent Atrial Fibrillation
por: Chikata, Akio, et al.
Publicado: (2021)

Short‐term use of oral amiodarone causing torsades de pointes
por: Yau, Stephen, et al.
Publicado: (2018)

Torsade de pointes induced by intravenous amiodarone therapy accompanied by marked augmentation of the transmural dispersion of repolarization in a patient with tachycardia‐induced‐cardiomyopathy
por: Yonai, Ryo, et al.
Publicado: (2020)

DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)

Complicated acute myocardial infarction with simultaneous occlusion of two coronary arteries
por: Nordkin, Irina, et al.
Publicado: (2020)

Sheathless guiding catheter from a femoral approach for complex percutaneous coronary interventions —An unusual solution for an often‐encountered problem
por: Israeli, Zeev, et al.
Publicado: (2019)

QT prolongation and torsades de pointes with psychotropic agents
por: Desai, Nagaraj, et al.
Publicado: (2015)

QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter–defibrillator: Case report and review of the literature
por: Wei, Anhua, et al.
Publicado: (2017)

Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial
por: Shojaee, Majid, et al.
Publicado: (2017)

Amiodarone-induced life-threatening torsade de pointes in an end-stage lung cancer patient receiving gefitinib
por: Han, Dan, et al.
Publicado: (2019)

QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
por: Malone, Katie, et al.
Publicado: (2020)

Multiple drugs: QTc prolongation and torsades de pointes: case report
Publicado: (2021)

Catatonic depression precipitated by amiodarone prescribed for atrial fibrillation
por: Rajagopal, Sundararajan
Publicado: (2015)

Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis
por: Lazzerini, Pietro Enea, et al.
Publicado: (2016)

Recurrent takotsubo with prolonged QT and torsade de pointes and left ventricular thrombus
por: Ahmed, Alaa Eldin K., et al.
Publicado: (2017)

Chloroquine/erythromycin: QT interval prolongation and Torsade de Pointes: case report
Publicado: (2020)

Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation
por: Zhang, Nixiao, et al.
Publicado: (2018)

Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
por: Alizadeh, Abolfath, et al.
Publicado: (2022)

Methadone induced torsades de pointes and ventricular fibrillation: A case review
por: Khalesi, Somayeh, et al.
Publicado: (2014)

A tale of 2 torsades: How to approach a patient with torsades de pointes and distinguish between classical and pseudo–torsades de pointes
por: Scheinman, Melvin, et al.
Publicado: (2022)

Predictors of time to conversion of new‐onset atrial fibrillation to sinus rhythm with amiodarone therapy
por: Dursun, Ihsan, et al.
Publicado: (2020)

PO-01-110 ATRIAL TORSADES DE POINTES POST COVID MYOCARDITIS
por: Nguyen, Bao, et al.
Publicado: (2023)

Antiarrhythmic Drugs for Atrial Fibrillation: Selected Features of Ventricular Repolarization That Facilitate Proarrhythmic Torsades de Pointes and Favor Inpatient Initiation
por: Reiffel, James A.
Publicado: (2021)

A case of Takotsubo cardiomyopathy showing two modes of initiation for ventricular fibrillation: Augmented J-wave and torsade de pointes with QT prolongation
por: Shimizu, Masato, et al.
Publicado: (2016)

QT Interval Prolongation as a Biomarker for Torsades de Pointes and Sudden Death in Drug Development
por: Sides, Gregory D.
Publicado: (2002)

Torsades de pointes induced by concomitant use of chlorpheniramine and propranolol: An unusual presentation with no QT prolongation
por: Ösken, Altuğ, et al.
Publicado: (2016)

The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department
por: Cole, Jon B., et al.
Publicado: (2020)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine
por: Sarayani, Amir, et al.
Publicado: (2021)

Correlation Between Donepezil and QTc Prolongation and Torsades de Pointes: A Very Rare Phenomenon
por: Malik, Bilal Haider, et al.
Publicado: (2019)

Mechanisms of fever-induced QT prolongation and torsades de pointes in patients with KCNH2 mutation
por: Usuda, Keisuke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gqs6gd37sbhe7676gb1n22ovra